Vivos Therapeutics
(NASDAQ) VVOS
Vivos Therapeutics Financials at a Glance
Market Cap
$6.30M
Revenue (TTM)
$19.57M
Net Income (TTM)
-$25.12M
EPS (TTM)
-$2.31
P/E Ratio
-0.20
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$0.45
Volume
36,808
Open
$0.50
Price
$0.45
Volume
36,808
Open
$0.50
Previous Close
$0.45
Daily Range
$0.45 - $0.50
52-Week Range
$0.38 - $7.95
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$0.45
Volume
36,808
Open
$0.50
Previous Close
$0.45
Daily Range
$0.45 - $0.50
52-Week Range
$0.38 - $7.95
Estimated Earnings Date
Aug 18, 2026
VVOS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vivos Therapeutics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
268
CEO
R. Kirk Huntsman
Website
www.vivos.comHeadquarters
Littleton, CO 80120, US
VVOS Financials
Key Financial Metrics (TTM)
Gross Margin
59.48%
Operating Margin
-115.47%
Net Income Margin
-128.36%
Return on Equity
-2239.18%
Return on Capital
-165.62%
Return on Assets
-100.30%
Earnings Yield
-5.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.30M
Shares Outstanding
13.89M
Volume
36.81K
Avg. Volume
1.73M
Financials (TTM)
Gross Profit
$11.64M
Operating Income
-$22.60M
EBITDA
-$23.53M
Operating Cash Flow
-$17.48M
Capital Expenditure
-$789.00K
Free Cash Flow
-$18.25M
Cash & ST Invst.
$2.11M
Total Debt
$12.27M
Vivos Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.14M
+70.5%
Gross Profit
$2.61M
+72.6%
Gross Margin
50.67%
N/A
Market Cap
$6.30M
N/A
Market Cap/Employee
$59.97K
N/A
Employees
105
N/A
Net Income
-$7.75M
-100.6%
EBITDA
-$7.30M
-97.9%
Quarterly Fundamentals
Total Cash
$2.11M
-9.9%
Total Debt
$12.27M
+776.9%
Accounts Receivable
$1.77M
+146.4%
Inventory
$0.00
N/A
Long Term Debt
$4.17M
+347.3%
Short Term Debt
$8.10M
+1634.3%
Return on Assets
-1.00%
N/A
Return on Invested Capital
-3.18%
N/A
Free Cash Flow
-$6.01M
-53.4%
Operating Cash Flow
-$6.01M
-58.3%